87
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants

, , , , , , , , & show all
Pages 1695-1705 | Published online: 23 Nov 2015

References

  • No authors listedSecondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study GroupLancet19933428882125512627901582
  • No authors listedWarfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II StudyLancet199434388996876917907677
  • HaynesRBYaoXDeganiAKripalaniSGargAMcDonaldHPInterventions to enhance medication adherenceCochrane Database Syst Rev20054CD00001116235271
  • FangMCGoASChangYWarfarin discontinuation after starting warfarin for atrial fibrillationCirc Cardiovasc Qual Outcomes20103662463120959565
  • EwenSRettig-EwenVMahfoudFBöhmMLaufsUDrug adherence in patients taking oral anticoagulation therapyClin Res Cardiol2014103317318223999974
  • ConnollySJEzekowitzMDYusufSEikelboomJOldgrenJParekhADabigatran versus warfarin in patients with atrial fibrillationN Engl J Med2009361191139115119717844
  • PatelMRMahaffeyKWGargJRivaroxaban versus warfarin in nonvalvular atrial fibrillationN Engl J Med20113651088389121830957
  • GrangerCBAlexanderJHMcMurrayJJApixaban versus warfarin in patients with atrial fibrillationN Engl J Med20113651198199221870978
  • GiuglianoRPRuffCTBraunwaldEEdoxaban versus warfarin in patients with atrial fibrillationN Engl J Med2013369222093210424251359
  • LiewAEikelboomJWO’DonnellMRandomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillationCurr Opin Cardiol201227433133922573171
  • DantasGCThrompsonBVMansonJATracyCSUpshurREPatients’ perspectives on taking warfarin: qualitative study in family practiceBMC Fam Pract200451515268764
  • KernanWNOvbiageleBBlackHRGuidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationStroke20144572160223624788967
  • LugerSHohmannCKraftPPrescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe – a multicentric evaluationInt J Stroke20149556957524828272
  • MoriskyDEAngAKrousel-WoodMWardHPredictive validity of a medication adherence measure for hypertension controlJ Clin Hypertens2008105348354
  • MoriskyDEDiMatteoMRImproving the measurement of self-reported medication nonadherence: final responseJ Clin Epidemiol2011643262263
  • Krousel-WoodMIslamTWebberLSReRNMoriskyDEMuntnerPNew medication adherence scale versus pharmacy fill rates in seniors with hypertensionAm J Manag Care2009151596619146365
  • WangYKongMCKoYPsychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarinThromb Haemost2012108478979522836920
  • ClaxtonAJCramerJPierceCA systematic review of the association between dose regimens and medication complianceClin Ther20012381296131011558866
  • US Food Drug AdministrationFDA drug safety communication 05/13/2014 on Pradaxa (dabigatran)Silver Spring MDUS Food and Drug Administration Available from: http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm397179.htmAccessed April 10, 2015
  • LewisWRFonarowGCGrau-SepulvedaMVImprovement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-StrokeAm Heart J2011162469269921982662
  • SauerRSauerEMBobingerTAdherence to oral anticoagulation in secondary stroke prevention – the first year of direct oral anticoagulantsJ Stroke Cerebrovasc Dis2015241788225440347
  • GliemMHermsenDvan RooijenNHartungHPJanderSSecondary intracerebral hemorrhage due to early initiation of oral anticoagulation after ischemic stroke: an experimental study in miceStroke201243123352335723117725